Pacific Biosciences Of California | PACB - Current Liabilities

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $63.21M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agilent USD 2.35B 455M Sep/2025
Bruker USD 1.28B 11.1M Dec/2025
Danaher USD 6.81B 483M Dec/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Illumina USD 1.59B 377M Dec/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Pacific Biosciences Of California USD 63.21M 3.45M Sep/2025
Quidel USD 966.1M 198.2M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Standard Biotools USD 107.96M 9.94M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Waters USD 1.25B 235.17M Sep/2025